4.6 Article

Spy1 enhances phosphorylation and degradation of the cell cycle inhibitor p27

Journal

CELL CYCLE
Volume 6, Issue 15, Pages 1937-1945

Publisher

LANDES BIOSCIENCE
DOI: 10.4161/cc.6.15.4520

Keywords

cyclin-dependent kinase; Speedy; RINGO; CDK2; Cdc2; cell cycle; cancer; p27Kip1

Categories

Funding

  1. NCI NIH HHS [T32CA009523, T32 CA009523] Funding Source: Medline

Ask authors/readers for more resources

The cyclin dependent kinase inhibitor (CKI) p27(Kip1) binds to cyclin E/CDK2 complexes and prevents premature S-phase entry. During late G(1) and throughout S-phase, p27 phosphorylation at T187 leads to its subsequent degradation, which relieves CDK2 inhibition to promote cell cycle progression. However, critical events that trigger CDK2 complexes to phosphorylate p27 remain unclear. Utilizing recombinant proteins, we demonstrate that human Speedy ( Spy1) activates CDK2 to phosphorylate p27 at T187 in vitro. Addition of Spy1 or Spy1/CDK2 to a preformed, inhibited cyclin E/CDK2/p27 complex also promoted this phosphorylation. Furthermore, Spy1 protected cyclin E/CDK2 from p27 inhibition toward histone H1, in vitro. Inducible Spy1 expression in U2OS cells reduced levels of endogenous p27 and exogenous p27(WT), but not a p27(T187A) mutant. Additionally, Spy1 expression in synchronized HeLa cells enhanced T187 phosphorylation and degradation of endogenous p27 in late G(1) and throughout S-phase. Our studies provide evidence that Spy1 expression enhances CDK2-dependent p27 degradation during late G(1) and throughout S-phase.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available